We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-17.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$47.7B
AUM Growth
-$12.1B
Cap. Flow
+$1.21B
Cap. Flow %
2.54%
Top 10 Hldgs %
20.23%
Holding
2,980
New
31
Increased
2,361
Reduced
322
Closed
49

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$22.7M
2
CNC icon
Centene
CNC
+$20M
3
IR icon
Ingersoll Rand
IR
+$18.4M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$16.8M
5
DLR icon
Digital Realty Trust
DLR
+$15.4M

Sector Composition

Rank Sector Weight
1 Technology 21.47%
2 Healthcare 14.79%
3 Financials 13.95%
4 Consumer Discretionary 9.78%
5 Communication Services 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LAUR icon
1501
Laureate Education
LAUR
$5.28B
$2.17M ﹤0.01%
206,674
+19,374
+10% +$335K
RGR icon
1502
Sturm, Ruger & Co
RGR
$593M
$2.17M ﹤0.01%
42,639
+462
+1% +$22.7K
TOWN icon
1503
Towne Bank
TOWN
$3.42B
$2.17M ﹤0.01%
119,827
+8,305
+7% +$204K
MODV
1504
DELISTED
ModivCare
MODV
$2.15M ﹤0.01%
39,200
+699
+2% +$43.3K
AIMC
1505
DELISTED
Altra Industrial Motion Corp
AIMC
$2.15M ﹤0.01%
122,976
+8,994
+8% +$267K
OXM icon
1506
Oxford Industries
OXM
$552M
$2.15M ﹤0.01%
59,159
+1,730
+3% +$106K
RITM icon
1507
Rithm Capital
RITM
$5.69B
$2.14M ﹤0.01%
426,878
+98,997
+30% +$1.43M
HSTM icon
1508
HealthStream
HSTM
$840M
$2.14M ﹤0.01%
89,199
+3,694
+4% +$92.8K
PATK icon
1509
Patrick Industries
PATK
$2.85B
$2.13M ﹤0.01%
113,567
+3,818
+3% +$122K
CYTK icon
1510
Cytokinetics
CYTK
$10.4B
$2.13M ﹤0.01%
180,633
+3,406
+2% +$43.5K
NVST icon
1511
Envista
NVST
$4.52B
$2.13M ﹤0.01%
142,372
+15,708
+12% +$402K
RNST icon
1512
Renasant Corp
RNST
$3.91B
$2.13M ﹤0.01%
97,405
+6,393
+7% +$190K
CHNG
1513
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$2.13M ﹤0.01%
212,787
+180,384
+557% +$2.52M
BPFH
1514
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
$2.12M ﹤0.01%
295,793
+13,223
+5% +$136K
EPZM
1515
DELISTED
Epizyme, Inc
EPZM
$2.11M ﹤0.01%
136,025
+9,977
+8% +$214K
BMCH
1516
DELISTED
BMC Stock Holdings, Inc
BMCH
$2.11M ﹤0.01%
119,014
+8,843
+8% +$231K
HHH icon
1517
Howard Hughes
HHH
$4.03B
$2.11M ﹤0.01%
43,740
+6,303
+17% +$632K
HTH icon
1518
Hilltop Holdings
HTH
$2.24B
$2.1M ﹤0.01%
139,089
+12,776
+10% +$271K
UIS icon
1519
Unisys
UIS
$217M
$2.1M ﹤0.01%
170,082
+4,620
+3% +$59.1K
PGRE
1520
DELISTED
Paramount Group
PGRE
$2.1M ﹤0.01%
238,683
+46,971
+25% +$582K
ANF icon
1521
Abercrombie & Fitch
ANF
$5B
$2.1M ﹤0.01%
230,844
+11,228
+5% +$163K
VRTS icon
1522
Virtus Investment Partners
VRTS
$1.1B
$2.08M ﹤0.01%
27,354
+2,194
+9% +$247K
APLS
1523
DELISTED
Apellis Pharmaceuticals
APLS
$2.07M ﹤0.01%
77,433
+12,185
+19% +$433K
TFIN icon
1524
Triumph Financial Inc
TFIN
$1.82B
$2.07M ﹤0.01%
79,695
+2,599
+3% +$90K
ACH
1525
Accendra Health
ACH
$214M
$2.06M ﹤0.01%
225,496
+14,063
+7% +$84.9K

Similar funds

RhumbLine Advisers's Q1 2020 Portfolio in Review

As of Q1 2020, RhumbLine Advisers held 2,980 positions worth $47.7B, down 20% from $59.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q1 2020: portfolio turnover was 2.7%. RhumbLine Advisers opened 31 new positions and exited 49, leaving the 2,980-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q1 2020 buy was PPD, Inc. Common Stock: 58,466 shares worth $1.04M.
  • RhumbLine Advisers added most to Prologis in Q1 2020, an estimated $22.7M increase.
  • RhumbLine Advisers's biggest Q1 2020 reduction was Apple, cutting an estimated $70.6M.
  • RhumbLine Advisers fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $34.9M.
  • RhumbLine Advisers's ten largest holdings make up 20% of its $47.7B portfolio in Q1 2020.
  • RhumbLine Advisers opened 31 new positions and closed 49 in Q1 2020.
  • RhumbLine Advisers's portfolio value fell 20% quarter-over-quarter to $47.7B.

Based on RhumbLine Advisers's 13F filing for Q1 2020, filed 6 May 2020.